Isolation and characterization of a pituitary tumor-transforming gene (PTTG)

Molecular Endocrinology

Volumn 11, Issue 4, 1997, Pages 433-441

  Pei, Lin ^a   Melmed, Shlomo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; GENE ISOLATION; GENE OVEREXPRESSION; HYPOPHYSIS TUMOR; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; RNA ANALYSIS;

ANIMALIA; MUS MUSCULUS;

EID: 0030910680     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.11.4.9911     Document Type: Article

References (31)

1. Alexander JM, Biller BMK, Bikkal H, Zervas NT, Arnold A, Klibanski A 1990 Clinically non-functioning pituitary tumors are monoclonal in origin. J Clin Invest 86:336-340
2. Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S 1990 Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71:1427-1433
3. Melmed S 1994 Pituitary neoplasia. Endocrinol Metab Clin North Am 23:81-92
4. Vallar L, Spada A, Giannattasio G Altered 1987 GSa and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 330:566-568
5. Landis CA, Masters SB, Spada A, Pase AM, Bourne HR, Vallar L 1989 GTPase inhibiting mutations activate the a chain of Gs and stimulate adenylyl cyclase in human pituitary tumors. Nature 340:692-696
6. Bertherat J, Chanson P, Montminy M 1995 The cyclic adenosine 3′,5′-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. Mol Endocrinol 9:777-783
7. Karga HJ, Alexander JM, Hedley-Whyte ET, Klibansky A, Jameson JL 1992 Ras mutation in human pituitary tumors. J Clin Endocrinol Metab 72:914-919
8. Pei L, Melmed M, Scheithauer B, Kovacs K, Prager, D 1994 H-ras mutations in human pituitary carcinoma metastases. J Clin Endocrinol Metab 78:842-846
9. Jacks T, Fazelli A, Schmitt E, Bronson RT, Goodell M, Weinberg RA 1992 Effects of an Rb mutation in the mouse. Nature 359:295-300
10. Clark AR, Maadag ER, van Roon M, van der Lugt NMT, van der Valk M, et al 1992 Requirement for a functional Rb-1 gene in murine development. Nature 359:328-330
11. Lee EY-HP, Chang C-Y, Hu N, Wang Y-CJ, Lai C-C, et al 1992 Mice deficient for Rb are nonviable and show defects in neurogenesis and hematopoiesis. Nature 359:288-294
12. D20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogens 9:1021-1027
13. Cryns VL, Alexander JM, Klibanski A, Arnold A 1993 The retinoblastoma gene in human pituitary tumors. J Clin Endocrinol Metab 77:644-646
14. Pei L, Melmed M, Scheithauer B, Kovacs K, Benedict WF, Prager D 1995 Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res 55:1613-1616
15. Herman V, Drazin NZ, Gonsky R, Melmed S 1993 Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab 77:50-55
16. Boggild MD, Jenkinson S, Pistorello M, Boscaro M, Scanarini M et al 1994 Molecular genetic studies of sporadic pituitary tumors. J Clin Endocrinol Metab 78:387-392
17. Thakker RV, Pook MA, Wooding C et al 1993 Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest 91:2815-2821
18. Peng L, Pardee AB 1992 Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967-971
19. Peng L, Averboukh L, Pardee AB 1993 Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res 21:3269-3257
20. Risinger JI, Terry LA, Boyd J 1994 Use of representational difference analysis for the identification of mdm2 oncogene amplification in diethyl-stilbestrol-induced murine uterine adenocarcinomas. Mol Carcinog 11:13-18
21. Qu D-Q, Ludwig DS, Gammmeltoft S, et al 1996 A role for melanin-concentraing hormone in the central regulation of feeding behaviour. Nature 380:243-247
22. Mosmann T 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 65:55-63
23. Carmichael J et al 1987 Evaluation of a tetrazolium-based semiauto-mated colorimetric assay: assessment of radiosensitivity. Cancer Res 47:943-946
24. Bancroft FC 1981 GH cells: Functional clonal lines of rat pituitary tumor cells. Functionally Differentiated Cell Lines. Alan R. Liss, New York, pp 47-59
25. Pei L, Melmed S 1996 Oncogenes and tumor suppressor genes in pituitary tumorigenesis. In: Melmed S (ed) Frontiers in Hormone Research. Karger, Basel, p. 136
26. Land H, Parada LF, Weinberg RA 1983 Tumorigenic conversion of primary embryo fibroblasts requires at least two operating oncogenes. Nature 304:696-602
27. Schwab M, Varmus HE, Bishop JM 1985 Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature 316:160-162
28. Ruley HE 1983 Adenovirus early region 1A enable viral and cellular transforming genes to transform primary cells in culture. Nature 304:602-606
29. Reynolds VL 1987 Regulation of a methallothioneinrasT24 fusion gene by zinc results in graded alterations in cell morphology and growth. Oncogene 1:323-330
30. Massague J 1990 The transforming growth factor-b family. Annu Rev Cell Biol 6:597-641
31. Cowley S, Paterson H, Kemp P, Marshall CJ 1994 Activation of MAP kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852